Eli Lilly is walking through the Gate, inking a deal worth up to $856 million with a biotech aiming to build out a new ...

Drugmaker Eli Lilly and Co. said Tuesday the leaders of its largest business unit and its global manufacturing operations will retire at the end of the year.

Less than a week after announcing it had a new CEO, privately held Creyon Bio Inc. began a licensing and research partnership with Eli Lilly and Co. Creyon is getting $13 million up front and could ...